Netrin-1 prevents ischemia/reperfusion-induced myocardial infarction via a DCC/ERK1/2/eNOSs1177/NO/DCC feed-forward mechanism

Journal of Molecular and Cellular Cardiology

Volumn 48, Issue 6, 2010, Pages 1060-1070

  Zhang, Jun ^a   Cai, Hua ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardioprotection; DCC; Electron spin resonance; ENOS; ERK1 2; Ischemia reperfusion; Myocardial infarction; Netrin 1; Nitric oxide

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N(G) NITROARGININE METHYL ESTER; NETRIN 1; NITRIC OXIDE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; C57BL 6 MOUSE; CELL ISOLATION; CELL TYPE; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; ISOLATED HEART; MALE; MOUSE; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; APOPTOSIS; CREATINE KINASE; ELECTRON SPIN RESONANCE SPECTROSCOPY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; NERVE GROWTH FACTORS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PERFUSION; RECEPTORS, CELL SURFACE; REPERFUSION INJURY; TUMOR SUPPRESSOR PROTEINS;

MUS;

EID: 77952675373     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.11.020     Document Type: Article

References (50)

1. Kennedy T.E., Serafini T., de la Torre J.R., Tessier-Lavigne M. Netrins are diffusible chemotropic factors for commissural axons in the embryonic spinal cord. Cell 1994, 78:425-435.
2. Serafini T., Kennedy T.E., Galko M.J., Mirzayan C., Jessell T.M., Tessier-Lavigne M. The netrins define a family of axon outgrowth-promoting proteins homologous to C. elegans UNC-6. Cell 1994, 78:409-424.
3. Serafini T., Colamarino S.A., Leonardo E.D., Wang H., Beddington R., Skarnes W.C., et al. Netrin-1 is required for commissural axon guidance in the developing vertebrate nervous system. Cell 1996, 87:1001-1014.
4. Park K.W., Crouse D., Lee M., Karnik S.K., Sorensen L.K., Murphy K.J., et al. The axonal attractant Netrin-1 is an angiogenic factor. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:16210-16215.
5. Carmeliet P., Tessier-Lavigne M. Common mechanisms of nerve and blood vessel wiring. Nature 2005, 436:193-200.
6. Nguyen A., Cai H. Netrin-1 induces angiogenesis via a DCC-dependent ERK1/2-eNOS feed-forward mechanism. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:6530-6535.
7. Wilson B.D., Ii M., Park K.W., Suli A., Sorensen L.K., Larrieu-Lahargue F., et al. Netrins promote developmental and therapeutic angiogenesis. Science 2006, 313:640-644.
8. Navankasattusas S., Whitehead K.J., Suli A., Sorensen L.K., Lim A.H., Zhao J., et al. The netrin receptor UNC5B promotes angiogenesis in specific vascular beds. Development 2008, 135:659-667.
9. Liu Y., Stein E., Oliver T., Li Y., Brunken W.J., Koch M., et al. Novel role for Netrins in regulating epithelial behavior during lung branching morphogenesis. Curr. Biol. 2004, 14:897-905.
10. Nikolopoulos S.N., Giancotti F.G. Netrin-integrin signaling in epithelial morphogenesis, axon guidance and vascular patterning. Cell Cycle 2005, 4:e131-5.
11. Tessier-Lavigne M., Goodman C.S. The molecular biology of axon guidance. Science 1996, 274:1123-1133.
12. Huber A.B., Kolodkin A.L., Ginty D.D., Cloutier J.F. Signaling at the growth cone: ligand-receptor complexes and the control of axon growth and guidance. Annu. Rev. Neurosci. 2003, 26:509-563.
13. Cirulli V., Yebra M. Netrins: beyond the brain. Nat. Rev. Mol. Cell Biol. 2007, 8:296-306.
14. Yebra M., Montgomery A.M., Diaferia G.R., Kaido T., Silletti S., Perez B., et al. Recognition of the neural chemoattractant Netrin-1 by integrins alpha6beta4 and alpha3beta1 regulates epithelial cell adhesion and migration. Dev. Cell 2003, 5:695-707.
15. Lu X., Le Noble F., Yuan L., Jiang Q., De Lafarge B., Sugiyama D., et al. The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system. Nature 2004, 432:179-186.
16. Larrivee B., Freitas C., Trombe M., Lv X., Delafarge B., Yuan L., et al. Activation of the UNC5B receptor by Netrin-1 inhibits sprouting angiogenesis. Genes Dev. 2007, 21:2433-2447.
17. Elrod J.W., Greer J.J., Bryan N.S., Langston W., Szot J.F., Gebregzlabher H., et al. Cardiomyocyte-specific overexpression of NO synthase-3 protects against myocardial ischemia-reperfusion injury. Arterioscler. Thromb. Vasc. Biol. 2006, 26:1517-1523.
18. Jones S.P., Greer J.J., Kakkar A.K., Ware P.D., Turnage R.H., Hicks M., et al. Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H276-282.
19. Pabla R., Buda A.J., Flynn D.M., Blesse S.A., Shin A.M., Curtis M.J., et al. Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion. Circ. Res. 1996, 78:65-72.
20. Siegfried M.R., Carey C., Ma X.L., Lefer A.M. Beneficial effects of SPM-5185, a cysteine-containing NO donor in myocardial ischemia-reperfusion. Am. J. Physiol. 1992, 263:H771-H777.
21. Hataishi R., Rodrigues A.C., Neilan T.G., Morgan J.G., Buys E., Shiva S., et al. Inhaled nitric oxide decreases infarction size and improves left ventricular function in a murine model of myocardial ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H379-H384.
22. Wang W., Reeves W.B., Ramesh G. Netrin-1 and kidney injury. I. Netrin-1 protects against ischemia-reperfusion injury of the kidney. Am. J. Physiol. Renal Physiol. 2008, 294(4):F739-F747.
23. Youn J.Y., Wang T., Cai H. An ezrin/calpain/PI3K/AMPK/AKT/eNOSs1179 signaling cascade mediating VEGF-dependent endothelial nitric oxide production. Circ. Res. 2009, 104:50-59.
24. Walford G., Loscalzo J. Nitric oxide in vascular biology. J. Thromb. Haemost. 2003, 1:2112-2118.
25. Chang J., Rao N.V., Markewitz B.A., Hoidal J.R., Michael J.R. Nitric oxide donor prevents hydrogen peroxide-mediated endothelial cell injury. Am. J. Physiol. 1996, 270:L931-L940.
26. Monastyrskaya E., Folarin N., Malyshev I., Green C., Andreeva L. Application of the nitric oxide donor SNAP to cardiomyocytes in culture provides protection against oxidative stress. Nitric. Oxide 2002, 7:127-131.
27. Hida A., Kawakami A., Miyashita T., Yamasaki S., Nakashima K., Tanaka F., et al. Nitric oxide acts on the mitochondria and protects human endothelial cells from apoptosis. J. Lab. Clin. Med. 2004, 144:148-155.
28. Ly N.P., Komatsuzaki K., Fraser I.P., Tseng A.A., Prodhan P., Moore K.J., et al. Netrin-1 inhibits leukocyte migration in vitro and in vivo. Proc. Natl. Acad Sci. U. S. A. 2005, 102:14729-14734.
29. Jones S.P., Bolli R. The ubiquitous role of nitric oxide in cardioprotection. J. Mol. Cell Cardiol. 2006, 40:16-23.
30. Jones S.P., Girod W.G., Palazzo A.J., Granger D.N., Grisham M.B., Jourd'Heuil D., et al. Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase. Am. J. Physiol. 1999, 276:H1567-H1573.
31. Brunner F., Maier R., Andrew P., Wolkart G., Zechner R., Mayer B. Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Cardiovasc. Res. 2003, 57:55-62.
32. Duranski M.R., Greer J.J., Dejam A., Jaganmohan S., Hogg N., Langston W., et al. Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J. Clin Invest. 2005, 115:1232-1240.
33. Bryan N.S., Calvert J.W., Elrod J.W., Gundewar S., Ji S.Y., Lefer D.J. Dietary nitrite supplementation protects against myocardial ischemia-reperfusion injury. Proc. Natl. Acad Sci. U. S. A. 2007, 104:19144-19149.
34. Hendgen-Cotta U.B., Merx M.W., Shiva S., Schmitz J., Becher S., Klare J.P., et al. Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia-reperfusion injury. Proc. Natl. Acad Sci. U. S. A. 2008, 105:10256-10261.
35. Moens A.L., Champion H.C., Claeys M.J., Tavazzi B., Kaminski P.M., Wolin M.S., et al. High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury. Circulation 2008, 117:1810-1819.
36. Fraser H., Davidge S.T., Clanachan A.S. Activation of Ca(2+)-independent nitric oxide synthase by 17beta-estradiol in post-ischemic rat heart. Cardiovasc. Res. 2000, 46:111-118.
37. Di Napoli P., Antonio Taccardi A., Grilli A., Spina R., Felaco M., Barsotti A., et al. Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts. Cardiovasc. Res. 2001, 51:283-293.
38. Abou-Agag L.H., Khoo N.K., Binsack R., White C.R., Darley-Usmar V., Grenett H.E., et al. Evidence of cardiovascular protection by moderate alcohol: role of nitric oxide. Free Radic. Biol. Med. 2005, 39:540-548.
39. Bulhak A.A., Sjoquist P.O., Xu C.B., Edvinsson L., Pernow J. Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1. Basic Res. Cardiol. 2006, 101:244-252.
40. Elrod J.W., Greer J.J., Lefer D.J. Sildenafil-mediated acute cardioprotection is independent of the NO/cGMP pathway. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H342-347.
41. Cai H., Li Z., Davis M.E., Kanner W., Harrison D.G., Dudley S.C. Akt-dependent phosphorylation of serine 1179 and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase 1/2 cooperatively mediate activation of the endothelial nitric-oxide synthase by hydrogen peroxide. Mol. Pharmacol. 2003, 63:325-331.
42. Chen D.B., Bird I.M., Zheng J., Magness R.R. Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells. Endocrinology 2004, 145:113-125.
43. Das A., Salloum F.N., Xi L., Rao Y.J., Kukreja R.C. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H1236-H1243.
44. Li D.Y., Tao L., Liu H., Christopher T.A., Lopez B.L., Ma X.L. Role of ERK1/2 in the anti-apoptotic and cardioprotective effects of nitric oxide after myocardial ischemia and reperfusion. Apoptosis 2006, 11:923-930.
45. Lips D.J., Bueno O.F., Wilkins B.J., Purcell N.H., Kaiser R.A., Lorenz J.N., et al. MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo. Circulation 2004, 109:1938-1941.
46. Gottlieb R.A., Burleson K.O., Kloner R.A., Babior B.M., Engler R.L. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J. Clin. Invest. 1994, 94:1621-1628.
47. Buerke M., Murohara T., Skurk C., Nuss C., Tomaselli K., Lefer A.M. Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc. Natl. Acad Sci. U. S. A. 1995, 92:8031-8035.
48. Liu X., Huang Y., Pokreisz P., Vermeersch P., Marsboom G., Swinnen M., et al. Nitric oxide inhalation improves microvascular flow and decreases infarction size after myocardial ischemia and reperfusion. J. Am. Coll. Cardiol. 2007, 50:808-817.
49. Feng Q., Song W., Lu X., Hamilton J.A., Lei M., Peng T., et al. Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase. Circulation 2002, 106:873-879.
50. Weiland U., Haendeler J., Ihling C., Albus U., Scholz W., Ruetten H., et al. Inhibition of endogenous nitric oxide synthase potentiates ischemia-reperfusion-induced myocardial apoptosis via a caspase-3 dependent pathway. Cardiovasc. Res. 2000, 45:671-678.